Q Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$4.1M

71 transactions

Summary

Q Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $100KSales: —10 insiders

Date	Insider	Type	Value
2015-09-09	BORST STEVEN JOHN(Chief Executive Officer)	A	$280K
2015-09-09	BORST STEVEN JOHN(Chief Executive Officer)	A	$280K
2014-12-18	EPPSTEIN DEBORAH ANNE(Chief Executive Officer)	A	$210K
2014-12-18	EPPSTEIN DEBORAH ANNE(Chief Executive Officer)	A	$200K
2014-12-18	Rao Mahendra S.(Chief Strategy Officer)	A	$175K
2014-12-18	BORST STEVEN JOHN(Chief Financial Officer)	A	$175K
2014-12-18	BORST STEVEN JOHN(Chief Financial Officer)	A	$150K
2015-09-09	BORST STEVEN JOHN(Chief Executive Officer)	A	$70K
2015-09-09	BORST STEVEN JOHN(Chief Executive Officer)	A	$70K
2015-09-09	BORST STEVEN JOHN(Chief Executive Officer)	A	$70K
2015-09-09	BORST STEVEN JOHN(Chief Executive Officer)	A	$70K
2014-12-18	GREBOW PETER E	A	$35K
2014-12-18	Jorkasky Diane	A	$35K
2014-12-18	HUTT PETER BARTON	A	$35K
2014-12-18	JACKSON HUNTER	A	$35K
2014-03-11	GREBOW PETER E	A	$35K
2015-09-09	EPPSTEIN DEBORAH ANNE	A	$11K
2014-07-14	HUTT PETER BARTON	M	$5K
2014-07-14	HUTT PETER BARTON	M	$5K
2015-12-31	BORST STEVEN JOHN(Chief Executive Officer)	G	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Q Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope